Detection of skin α-synuclein using RT-QuIC as a diagnostic biomarker for Parkinson's disease in the Chinese population
- PMID: 38336827
- PMCID: PMC10854029
- DOI: 10.1186/s40001-024-01705-x
Detection of skin α-synuclein using RT-QuIC as a diagnostic biomarker for Parkinson's disease in the Chinese population
Abstract
Background: Several studies have indicated that skin holds promise as a potential sample for detecting pathological α-Syn and serving as a diagnostic biomarker for α-synucleinopathies. Despite reports in Chinese PD patients, comprehensive research on skin α-Syn detection using RT-QuIC is lacking.
Objective: This study aimed to evaluate the diagnostic performance of skin samples using RT-QuIC from PD patients in the Chinese population.
Methods: Patients with sporadic PD and controls were included according to the British PD Association Brain Bank diagnostic criteria. The seeding activity of misfolded α-Syn in these skin samples was detected using the RT-QuIC assay after protein extraction. Biochemical and morphological analyses of RT-QuIC products were conducted by atomic force microscopy, transmission electron microscopy, Congo red staining, and dot blot analysis.
Result: 30 patients clinically diagnosed with PD and 28 controls with non-α-synucleinopathies were included in this study. 28 of 30 PD patients demonstrated positive α-Syn seeding activity by RT-QuIC assay. In contrast, no α-Syn seeding activity was detected in the 28 control samples, with an overall sensitivity and specificity of 93.3% and 100%, respectively (P < 0.001). Biochemical characterization of the RT-QuIC product indicated fibrillary α-Syn species in PD-seeded reactions, while control samples failed in the conversion of recombinant α-Syn substrate.
Conclusion: This study applied RT-QuIC technology to identify misfolded α-Syn seeding activity in skin samples from Chinese PD patients, demonstrating high specificity and sensitivity. Skin α-Syn RT-QuIC is expected to be a reliable approach for the diagnosis of PD.
Keywords: Parkinson’s disease; RT-QuIC; Skin; α-synuclein.
© 2024. The Author(s).
Conflict of interest statement
The authors have no relevant financial or non-financial interests to disclose.
Figures



Similar articles
-
Combining salivary α-synuclein seeding activity and miRNA-29a to distinguish Parkinson's disease and multiple system atrophy.Parkinsonism Relat Disord. 2024 Oct;127:107088. doi: 10.1016/j.parkreldis.2024.107088. Epub 2024 Aug 5. Parkinsonism Relat Disord. 2024. PMID: 39111257
-
Seeding variability of different alpha synuclein strains in synucleinopathies.Ann Neurol. 2019 May;85(5):691-703. doi: 10.1002/ana.25446. Epub 2019 Mar 27. Ann Neurol. 2019. PMID: 30805957
-
Diagnostic Value of Salivary Real-Time Quaking-Induced Conversion in Parkinson's Disease and Multiple System Atrophy.Mov Disord. 2022 May;37(5):1059-1063. doi: 10.1002/mds.28976. Epub 2022 Mar 12. Mov Disord. 2022. PMID: 35278004
-
Misfolded alpha-synuclein detection by RT-QuIC in dementia with lewy bodies: a systematic review and meta-analysis.Front Mol Biosci. 2023 May 17;10:1193458. doi: 10.3389/fmolb.2023.1193458. eCollection 2023. Front Mol Biosci. 2023. PMID: 37266333 Free PMC article. Review.
-
The α-Synuclein Seeding Amplification Assay for Parkinson's Disease.Int J Mol Sci. 2025 Jan 4;26(1):389. doi: 10.3390/ijms26010389. Int J Mol Sci. 2025. PMID: 39796243 Free PMC article. Review.
Cited by
-
Skin α-synuclein assays in diagnosing Parkinson's disease: a systematic review and meta-analysis.J Neurol. 2025 Apr 9;272(5):326. doi: 10.1007/s00415-025-12978-5. J Neurol. 2025. PMID: 40205187
-
Nanotechnology meets medicine: applications of atomic force microscopy in disease.Biophys Rev. 2025 Apr 3;17(2):359-384. doi: 10.1007/s12551-025-01306-w. eCollection 2025 Apr. Biophys Rev. 2025. PMID: 40376402 Free PMC article. Review.
-
Redefining Non-Motor Symptoms in Parkinson's Disease.J Pers Med. 2025 Apr 26;15(5):172. doi: 10.3390/jpm15050172. J Pers Med. 2025. PMID: 40423044 Free PMC article. Review.
-
RT-QuIC: a highly promising diagnostic method for neurodegenerative diseases-advantages and limitations.Front Neurol. 2025 May 27;16:1578252. doi: 10.3389/fneur.2025.1578252. eCollection 2025. Front Neurol. 2025. PMID: 40496124 Free PMC article. Review.
-
Navigating the Neurobiology of Parkinson's: The Impact and Potential of α-Synuclein.Biomedicines. 2024 Sep 18;12(9):2121. doi: 10.3390/biomedicines12092121. Biomedicines. 2024. PMID: 39335634 Free PMC article. Review.
References
-
- Shi S, Mitteregger-Kretzschmar G, Giese A, Kretzschmar HA. Establishing quantitative real-time quaking-induced conversion (qRT-QuIC) for highly sensitive detection and quantification of PrPSc in prion-infected tissues. Acta Neuropathol Commun. 2013;1:44. doi: 10.1186/2051-5960-1-44. - DOI - PMC - PubMed
-
- Fairfoul G, McGuire LI, Pal S, Ironside JW, Neumann J, Christie S, Joachim C, Esiri M, Evetts SG, Rolinski M, Baig F, Ruffmann C, Wade-Martins R, Hu MT, Parkkinen L, Green AJ. Alpha-synuclein RT-QuIC in the CSF of patients with alpha-synucleinopathies. Ann Clin Transl Neurol. 2016;3:812–818. doi: 10.1002/acn3.338. - DOI - PMC - PubMed
-
- Shahnawaz M, Tokuda T, Waragai M, Mendez N, Ishii R, Trenkwalder C, Mollenhauer B, Soto C. Development of a biochemical diagnosis of Parkinson disease by detection of alpha-synuclein misfolded aggregates in cerebrospinal fluid. JAMA Neurol. 2017;74:163–172. doi: 10.1001/jamaneurol.2016.4547. - DOI - PubMed
-
- Bongianni M, Ladogana A, Capaldi S, Klotz S, Baiardi S, Cagnin A, Perra D, Fiorini M, Poleggi A, Legname G, Cattaruzza T, Janes F, Tabaton M, Ghetti B, Monaco S, Kovacs GG, Parchi P, Pocchiari M, Zanusso G. alpha-Synuclein RT-QuIC assay in cerebrospinal fluid of patients with dementia with Lewy bodies. Ann Clin Transl Neurol. 2019;6:2120–2126. doi: 10.1002/acn3.50897. - DOI - PMC - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous